MLLT11 Polyclonal Antibody, Biotin Conjugated, Rabbit

Catalog Number: BSS-BS-8562R-BIOTIN
Article Name: MLLT11 Polyclonal Antibody, Biotin Conjugated, Rabbit
Biozol Catalog Number: BSS-BS-8562R-BIOTIN
Supplier Catalog Number: bs-8562R-Biotin
Alternative Catalog Number: BSS-BS-8562R-BIOTIN-100
Manufacturer: Bioss
Host: Rabbit
Category: Antikörper
Application: ELISA, IHC-Fr, IHC-P
Conjugation: Biotin
Alternative Names: AF1Q, ALL1 fused gene from chromosome 1q, MLLT 11, MLLT-11, Myeloid/lymphoid or mixed lineage leukemia trithorax homolog, Drosophila translocated to 11, Protein AF1q, RP11 316M1.10.
The gene encoding the Mixed-Lineage Leukemia (MLL) proteins is located on chromosome 11q23. Chromosomal translocations involving band 11q23 result in rogue activator proteins that are associated with approximately 10% of patients with acute lymphoblastic leukemia (ALL) and 5% of patients with acute myeloid leukemia (AML). Most patients affected are less than 1 year of age. MLLT11, also known as mixed-lineage leukemia translocated to 11 or AF1q, is a 90 amino acid MLL fusion partner. Based on the expression patterns of MLLT11, it is thought that MLLT11 plays a role in leukemogenesis and, specifically, the progression of acute monocytic leukemia (AML). Also, expressed in embryonic brain cortex, MLLT11 is upregulated during neuronal differentiation and is thought to play a role in the development of the central nervous system. Finally, MLLT11 has been shown to be differentially expressed in highly metastatic cells, in comparison with non-metastatic parent cells. Such findings suggest a role of MLLT11 in tumorigenesis.
Clonality: Polyclonal
Concentration: 1ug/ul
NCBI: 10962
Buffer: Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Source: KLH conjugated synthetic peptide derived from human MLLT11
Target: MLLT11
Application Dilute: ELISA(1:500-1000), IHC-P(1:200-400), IHC-F(1:100-500)